Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease.
about
A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease PathogenesisThe endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive diseaseHypothalamic-pituitary-gonadal axis involvement in learning and memory and Alzheimer's disease: more than "just" estrogenImago Mundi, Imago AD, Imago ADNILuteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Sex differences in cognitive impairment and Alzheimer's disease.Elevated mRNA-levels of gonadotropin-releasing hormone and its receptor in plaque-bearing Alzheimer's disease transgenic miceKnowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer's disease.Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer's diseaseSex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau proteinLuteinizing hormone: Evidence for direct action in the CNSEffects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell LineNeuroendocrine immunomodulation network dysfunction in SAMP8 mice and PrP-hAβPPswe/PS1ΔE9 mice: potential mechanism underlying cognitive impairment.The Effects of Testosterone Supplementation on Cognitive Functioning in Older MenKnowledge-Based Compact Disease Models: A Rapid Path from High-Throughput Data to Understanding Causative Mechanisms for a Complex Disease.Amyloid and Tau Biomarkers in Subjective Cognitive Impairment.Presence of Androgen Receptor Variant in Neuronal Lipid Rafts.The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.Metabolomics and cognition in African American adults in midlife: the atherosclerosis risk in communities study.Sex hormones and brain volumes in a longitudinal study of middle-aged men in the CARDIA study.Involvement of Luteinizing Hormone in Alzheimer Disease Development in Elderly Women.Apolipoprotein E e4 Allele Is Associated with Subjective Cognitive Decline: A Meta-Analysis.Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen LossGenetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer's Disease
P2860
Q26781496-829DB72F-92B4-43C9-A5E4-09C5436EB864Q26799258-9A68D900-94A3-4C01-88CC-A867BC29C852Q27027598-572779D5-4761-4041-9BC1-205AC6F95BF2Q28650395-996431EC-B239-4FB8-A238-DBFE57DF5383Q30354338-84C9082B-EED5-4FE2-89F2-0495BAF9F819Q30831806-09A7C9CA-DD07-4045-8322-8357902CA5E6Q30996727-48AC8317-21DA-48FE-8B39-9446DFC53C4DQ33864547-83C7F2EF-5E3E-4AC9-AE22-44F4BBA8715CQ33999164-4D8F7346-BA24-4189-ACE3-77D92BA316A2Q35033039-5A84C5E9-FE76-4C06-9260-7B0EA969B529Q35559314-625A8A29-624C-4D55-B8DA-D2D93664B00EQ36426980-7CC55BF9-7F54-450A-89C3-DE366BF51609Q36543895-9971BDFE-FF19-4AD7-A1EE-160B4E93F94DQ37057444-817C2EE6-4B22-40B9-9D59-3744794C81C5Q37268924-20C68D55-8159-4E2F-8465-52228C05899AQ37363540-AB401154-A177-41CC-89CA-8D4CCB200F41Q38371546-C319B49C-F451-4850-ADC8-FEB13CB82641Q38592259-F52106CA-3BB2-46E9-A29E-2CDFBEE1F7B2Q38693739-03B6D8DC-EEC6-4AF4-8FAC-7CE72CF62D47Q38927944-47EDB643-E7D7-49EE-9997-472B1C90E203Q39401091-6A08096A-36DE-4D0A-9CAC-546370FF3DD3Q41196957-2A333673-95EA-4CCF-9242-B02C997DD2CDQ42656029-E080C7B4-D3B6-464A-8016-4A59EFCB01E8Q48614782-EDEE455D-E0B3-47A1-8809-BCA3806514E8Q49712694-3C2E8289-E9B5-4550-9E45-5E68CA4974A3Q51760876-5D9C259C-8660-4C49-9206-DFD2A880EA3DQ55071408-8818D993-0412-4383-BFBB-4B10CEBFD9F8Q57492371-C3EF20F5-D4CC-4BE7-8DBE-88DA0BF6C4CCQ58797229-9074859B-CD6A-4D52-9E53-EF076F01FC96
P2860
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Associations between gonadotro ...... t risk of Alzheimer's disease.
@en
Associations between gonadotro ...... t risk of Alzheimer's disease.
@nl
type
label
Associations between gonadotro ...... t risk of Alzheimer's disease.
@en
Associations between gonadotro ...... t risk of Alzheimer's disease.
@nl
prefLabel
Associations between gonadotro ...... t risk of Alzheimer's disease.
@en
Associations between gonadotro ...... t risk of Alzheimer's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
Associations between gonadotro ...... at risk of Alzheimer's disease
@en
P2093
AIBL Research Group
C L Masters
V L Villemagne
P2860
P2888
P356
10.1038/MP.2012.147
P407
P50
P577
2012-10-23T00:00:00Z